MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,755K
EPS
-$0.41
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
-
0
640*
875
Research and development
-
730
383*
348
General and administrative
1,771
2,479
1,535*
1,533
Total cost and expenses
1,771
3,209
1,918*
1,881
Loss from operations
-1,771
-3,209
-1,278*
-1,006
Interest income
16
32
38*
30
Gain from settlement of account payable
-
-
0*
0
Gain from insurance recovery
-
-
1,363*
0
Total other income, net
16
32
1,401*
30
Net loss
-
-
122*
-976
Foreign currency translation adjustment loss
-
-
0*
0
Comprehensive loss
-
-
122
-976
Net loss and other comprehensive loss
-1,755
-3,177
-
-
Basic EPS
-0.41
-0.76
0.032
-0.3
Diluted EPS
-0.41
-0.76
0.032
-0.3
Basic Average Shares
4,251,000
4,205,000
3,762,000
3,225,000
Diluted Average Shares
4,251,000
4,205,000
3,762,000
3,225,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$16K
Net loss and other
comprehensive loss
-$1,755K
Total other income,
net
$16K
Loss from operations
-$1,771K
Total cost and
expenses
$1,771K
General and
administrative
$1,771K
Buy us a coffee
Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics, Inc. (CYCN)